HUNTSVILLE, Ala., April 15, 2025 (Newswire.com) – Curiteva, Inc., a pioneering technology and manufacturing company, is pleased to announce a significant achievement with over 5,000 levels successfully treated using the Inspire Cervical implant, just two years after its first surgical use in April 2023. This milestone highlights the continued adoption of the novel 3D printed trabecular PEEK implant, further establishing Curiteva’s presence as a leader in spine innovation.

Huntsville, AL., (December 3, 2024) – Curiteva, Inc., a privately held manufacturing and technology company, today announced it has implanted over 2,000 patients with the Inspire®C Cervical Interbody Fusion Device. This success translates to more than 3,700 implants placed, demonstrating the system’s rapid adoption and effectiveness since its commercial launch in July 2023.

Anterior cervical discectomy and fusion (ACDF) is a common procedure for the surgical treatment of degenerative pathologies of the cervical spine. The utilization of interbody fusion implants is a well-established technique to restore disk space height, alignment, decompress the exiting nerve roots, and provide surface area for fusion of the adjacent vertebrae. Successful fusion is critical for the long-term stability and function of the cervical spine and for maintenance of the overall clinical outcome. Polyetheretherketone (PEEK) is a material commonly used for interbody fusion implants. Benefits of PEEK include radiolucency, less stress shielding compared to titanium implants and improved modulus which may provide better loading characteristic. The ability to better visualize the fusion at the osseous-implant junction is a benefit preferred by many surgeons. Click here to read the full white paper.

Huntsville, AL (June 19, 2024) – Curiteva, Inc., a leading technology and manufacturing company, announces the commercial launch of the first of many offerings in its FDA cleared Inspire Posterior Interbody Fusion Solutions. Developed to enhance patient outcomes of transforaminal lumbar procedures, this 3D Printed Trabecular PEEK with HAFUSE Technology interbody boasts an optimized interconnected porous structure, promoting bone in-growth into and through the entire device.  

Huntsville, AL., (June 4, 2024) – Curiteva, Inc., a privately held manufacturing and technology company, announces over 1,000 patients have been treated with the novel 3D printed Inspire Cervical Trabecular PEEK Interbody Fusion System, resulting in over 2,000 Inspire implants placed in patients. The Inspire Cervical System was introduced with limited launch in April of 2023, followed by full commercialization in July.

Huntsville, AL., (May 21, 2024) – Curiteva, Inc., announced today the addition of Chris Schultz as Vice President of Marketing to the rapidly growing technology company headquartered in Huntsville, Alabama. This addition is part of a recently initiated strategy to enhance the company’s brand and propel Curiteva towards the next level of innovation and growth. This effort aligns with the company’s ongoing commitment to innovation, marked by the continuous introduction of products with its novel Inspire Technology. 

Huntsville, AL (April 26, 2024) – Curiteva, a privately held manufacturing and technology company announces the appointment of David Schmidt as Chief Commercial Officer, marking a significant milestone in the company’s mission to advance innovative technology in patient care. With a distinguished career spanning over two decades, Mr. Schmidt brings unparalleled expertise in commercial strategy and a proven track record of success in the medical device marketplace.

Huntsville, AL (February 12, 2024) – Curiteva, a privately held manufacturing and technology company announces the appointment of Kevin Foley, MD, to the board of directors. Dr. Foley is a distinguished neurosurgeon, chairman of the Semmes Murphey Neurologic and Spine Institute and a professor of neurosurgery, orthopedic surgery, and biomedical engineering at the University of Tennessee Health Science Center. 

Huntsville, AL based technology manufacturer Curiteva announced FDA 510(k) clearance of the Inspire 3D Printed Trabecular PEEK Lumbar Interbody Fusion System for use in anterior, transforaminal, posterior, and lateral lumbar interbody fusion procedures. This marks the company’s second FDA cleared 3D printed PEEK implant with HAFUSE, following the approval of the Inspire Trabecular PEEK Cervical Interbody Fusion System in February 2023.

Curiteva, a privately held technology and manufacturing company based in Huntsville, AL, is proud to announce the commercial launch of its Prowess Laminoplasty System. The system is designed to provide surgeons with the tools they need to perform posterior decompression of the cervical spine with greater precision, accuracy, and efficiency.